Back to search

Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly

Data up to Jan 2025

Published1990
Citations133
References31

Total Citations Per Year

Abstract

References (31)

Effects of Sex and Age on the 24-Hour Profile of Growth Hormone Secretion in Man: Importance of Endogenous Estradiol Concentrations*

1987 • 927 citations

Impaired growth hormone secretion in the adult population: relation to age and adiposity.

1981 • 643 citations

Somatostatin

1983 • 581 citations

Somatostatinoma Syndrome

1979 • 400 citations

Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995

1985 • 396 citations

The Role of Somatostatin in the Regulation of Anterior Pituitary Hormone Secretion and the Use of Its Analogs in the Treatment of Human Pituitary Tumors

1988 • 271 citations

Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients

1988 • 265 citations

Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut

1989 • 258 citations

Somatomedin-C Levels in Healthy Young and Old Men: Relationship to Peak and 24-Hour Integrated Levels of Growth Hormone

1985 • 205 citations

Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*

1987 • 132 citations

SMS 201–995 Induces a Continuous Decline in Circulating Growth Hormone and Somatomedin-C Levels During Therapy of Acromegalic Patients for Over Two Years

1987 • 127 citations

Neurosurgical management of acromegaly

1979 • 125 citations

Treatment of Acromegaly with the Long-Acting Somatostatin Analog SMS 201-995*

1988 • 112 citations

Transsphenoidal microsurgical removal of growth hormone-secreting pituitary adenomas

1982 • 103 citations

A Comparison among the Growth Hormone-Lowering Effects in Acromegaly of the Somatostatin Analog SMS 201-995, Bromocriptine, and the Combination of Both Drugs

1986 • 99 citations

LONG‐TERM RESULTS OF TRANSSPHENOIDAL PITUITARY MICROSURGERY IN 60 ACROMEGALIC PATIENTS

1985 • 96 citations

Long term treatment of acromegaly with a long acting analogue of somatostatin.

1985 • 94 citations

Acromegaly: Biochemical Assessment of Cure after Long Term Follow-Up of Transsphenoidal Selective Adenomectomy*

1985 • 87 citations

CONTINUOUS SUBCUTANEOUS PUMP INFUSION OF SOMATOSTATIN ANALOGUE SMS 201‐995 VERSUS SUBCUTANEOUS INJECTION SCHEDULE IN ACROMEGALIC PATIENTS

1987 • 87 citations

Dose-Response Study and Long Term Effect of the Somatostatin Analog Octreotide in Patients with Therapy-Resistant Acromegaly*

1989 • 80 citations

The Treatment of Acromegaly by Transsphenoidal Surgery

1980 • 70 citations

EVALUATION OF THE RESULTS OF TRANS-SPHENOIDAL SURGERY IN ACROMEGALY BY ASSESSMENT OF THE GROWTH HORMONE RESPONSE TO THYROTROPHIN-RELEASING HORMONE

1978 • 58 citations

GALLBLADDER DISEASE AND CHOLECYSTECTOMY RATE ARE INDEPENDENTLY VARIABLE

1984 • 57 citations

Clinical Applications of Somatostatin Analogs

1985 • 55 citations

Relationship between Receptor Binding and Biopotency of Somatostatin-14 and Somatostatin-28 in Mouse Pituitary Tumor Cells*

1985 • 54 citations

The Response of Serum Growth Hormone Levels to the Long-Acting Somatostatin Analog SMS 201-995 in Acromegaly

1987 • 54 citations

Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients

1980 • 53 citations

EFFECTIVE LONG‐TERM TREATMENT OF ACROMEGALY WITH A LONG‐ACTING SOMATOSTATIN ANALOGUE (SMS 201–995)

1987 • 52 citations

Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly

1986 • 43 citations

Clinical and endocrinological evaluation of 16 acromegalic patients treated by transsphenoidal surgery

1977 • 29 citations

Glucose tolerance during long term treatment with a somatostatin analogue.

1986 • 27 citations

Cited By (0)

Loading...